��������

Brett Lund is the chief licensing officer at Secura Bio. Lund was named “Best Corporate Counsel” by the Denver Business Journal, one of Colorado’s “Top Twenty-Five Most Influential Young Professionals” by ColoradoBiz Magazine, and “Forty Under 40” by the Denver Business Journal for being one of the top forty business leaders under age 40. Lund is currently a board member of the Colorado BioScience Association, Gevo Development, and the Colorado Cleantech Industry Association.

Prior to joining Secura Bio, Lund was the CEO and co-founder of Agarigen, Inc., which he successfully sold to Intrexon, Inc. Lund also previously served as chairman of the legal, IP, and licensing group for Syngenta Biotechnology Inc.’s biofuels business. In his role at Syngenta, Lund led the management of intellectual property, in-licensing, out-licensing, research collaborations, and strategic alliances. Prior to Syngenta, he served as associate general counsel for the Ford Motor Company’s Wingcast subsidiary.

Lund was previously a corporate attorney at the law firm of Cooley LLP, where he represented numerous companies regarding intellectual property licensing, IPOs, venture capital financing, M&A, securities, strategic alliances, and related transactions.

Lund holds a J.D from Duke University Law School, an M.B.A. from Duke University’s Fuqua School of Business, and a B.A. in political science from the University of California, San Diego. He is a Certified Licensing Professional by the Licensing Executives Society and admitted to practice law in California and North Carolina. Lund has also been a member of the American Bar Association, California Bar Association, North Carolina Bar Association, the Licensing Executives Society (LES), and the Association of University Technology Managers (AUTM).